AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Long Term Provisions History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Long Term Provisions | ₹226 Cr | ₹173 Cr | ₹172 Cr | ₹157 Cr | ₹75 Cr |
What is the latest Long Term Provisions ratio of AUROBINDO PHARMA ?
Year | Long Term Provisions |
---|---|
Mar2024 | ₹226 Cr |
Mar2023 | ₹173 Cr |
Mar2022 | ₹172 Cr |
Mar2021 | ₹157 Cr |
Mar2020 | ₹75 Cr |
How is Long Term Provisions of AUROBINDO PHARMA Trending?
Years | Long Term Provisions | % Change | |
---|---|---|---|
Mar2024 | ₹226 Cr | 30.67 | |
Mar2023 | ₹173 Cr | 0.54 | |
Mar2022 | ₹172 Cr | 9.34 | |
Mar2021 | ₹157 Cr | 110.29 | |
Mar2020 | ₹75 Cr | - |
Compare Long Term Provisions of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹66,437.7 Cr | -2.3% | -4.8% | -8.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,420.0 Cr | -0.2% | -2.9% | 12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,572.0 Cr | 0.3% | 6.5% | 49% | Stock Analytics | |
CIPLA | ₹123,329.0 Cr | 1.1% | 1.8% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,396.0 Cr | -0.2% | 9.5% | 12.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,956.0 Cr | 1.9% | 0.4% | 14% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -2.3% |
-4.8% |
-8.4% |
SENSEX | -0.8% |
-0.9% |
6.9% |
You may also like the below Video Courses